Read news on GLP-1 with our app.
Read more in the app
Why GLP-1 Weight-Loss Drugs Are Hard to Make into Pills
Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome - EurekAlert!
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer’s disease - EurekAlert!
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease
What foods and drinks are consumed less by those on GLP-1 weight-loss meds? - EurekAlert!
What do GLP-1 drugs really tell us about the brain's reward system?
GLP-1 drugs are only the start – the powerful drugs to expect next
Microdosing GLP-1 drugs is on the rise – but does it work?
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Cocaine user experiences reduced withdrawal cravings with GLP-1 therapy, case study reports
Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologists - EurekAlert
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditions
How GLP-1 drugs like Ozempic and Wegovy affect risk of 175 conditions
GLP-1 drugs may reduce surgery complications in patients with diabetes - EurekAlert
Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity
Key factors that impact long-term weight loss in patients prescribed GLP-1 RA medications
A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment
The benefits of GLP-1 drugs beyond obesity
